Dr. Roberts, Dr. Healey, Dr. Krahn

Subcutaneous-ICD versus Transvenous-ICD in ARVC Dr. Jeff Healey (S-ICD) Dr. Erkan Ilhan (TV-ICD) Moderators: Dr. Habub Khan, Dr. Jacqueline Joza

Dr. Andrew Krahn: My approach to Exercise in LQTS and CPVT KEYNOTE - Dr. Dominic Abrams: My approach to Exercise in HCM KEYNOTE - Dr. Cindy James: What is an Optimal Exercise Prescription in ARVC? Discussion: 9:35-9:45am Moderators: Dr. Simon Hansom, Dr. Christian Steinberg, Ms. Kristina Basma

Moderator: Dr. Jason Roberts Gene Therapies in Inherited Cardiac Disease - Session 1: Industry Panel 1. Tenaya Therapeutics: Dr. Jeff Haroldosn 2. Rocket Pharmaceuticals: Dr. Jonathan Schwartz 10:40-11:00am: Discussion Moderators: Dr. Thomas Roston, Dr. Joseph Atallah, Ms. Paule Corneil

Moderator: Dr. Zachary Laksman 11:00 - 11:05: Dr. Andrew Krahn: AI Use Case - Unexplained Cardiac Arrest 11:05 - 11:20: Dr. Robert Avram: Maximizing Large Language Model Utility in Cardiac Care 11:20 - 11:30: Dr. River Jiang: AI and Arrhythmias: The Long QT project 11:30 - 11:40: Dr. Chris Cheung: AI and Cardiomyopathy: The ARVC project 11:40 - 11:45: Dr. Zachary Laksman: AI Across the Spectrum of Research 11:45-12:00pm Panel Discussion

Session 2: Industry Panel 1. Thryv: Dr. Saumya Da 2. Cardurion: Dr. Howard Surks 1:15-1:25pm: Discussion Moderators: Dr. Ciorsti MacIntyre, Dr. Robert Hamilton

Dr. Thomas Roston: Myosin ATPase inhibitors in HCM 1:40-1:50pm: Discussion Moderator: Dr. Arnon Adler

Dr. Simon Hansom (Quinidine) versus Dr. Alexios Hadjis (Ablation) 2:05-2:15pm: Discussion Moderators: Dr. Mouhanned Sadek, Dr. Paul Angaran

Session 3 - Industry Panel 1. Solid - Dr. Gabriel Brooks 2. Lexeo - Dr. Richie Khan 2:55-3:15pm: Discussion Moderators: Dr. Shu Sanatani, Dr. Chris Simpson, Mr. Evan Kreuger

Industry Panel 4 Intellia - Dr. Liron Walsh 3:30-3:45pm: Panel Discussion Moderators: Dr. Rafik Tadros, Dr. Mike Gollob

Moderators: Dr. David Lee, Dr. Martin Green Dr. Julia Cadrin-Tourigny: My Approach to Risk Stratification in Arrhythmogenic Right Ventricular Cardiomypathy Dr. Christian Steinberg: Who Needs a Primary Prevention Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy Dr. Ciorsti MacIntyre: When to Consider an Implantable Cardioverter Defibrillator in Long QT Syndrome in 2024

Dr. Rafik Tadros Moderators: Dr. Jason Roberts, Ms. Susan Christian

Executive Committee - Ms. Brianna Davies Governance Committee: Dr. Colette Seifer Research Committee: Dr. Jason Roberts Clinical Care Committee: Drs. Colette Seifer & Susan Christian HiRO Karen Gibbs Bursary: Dr. Andrew Krahn